Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 136,417,584
  • Shares Outstanding, K 2,262,690
  • Annual Sales, $ 26,145 M
  • Annual Income, $ 3,439 M
  • 60-Month Beta 0.73
  • Price/Sales 5.21
  • Price/Cash Flow 13.71
  • Price/Book 2.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 1.43
  • Number of Estimates 4
  • High Estimate 1.51
  • Low Estimate 1.31
  • Prior Year 1.18
  • Growth Rate Est. (year over year) +21.19%

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.07 +10.15%
on 06/15/20
62.17 -4.20%
on 06/09/20
-1.87 (-3.04%)
since 06/08/20
3-Month
54.07 +10.15%
on 06/15/20
65.34 -8.85%
on 05/15/20
+1.31 (+2.25%)
since 04/08/20
52-Week
42.48 +40.21%
on 07/23/19
68.34 -12.85%
on 01/22/20
+13.79 (+30.13%)
since 07/08/19

Most Recent Stories

More News
Signs That Your Trading Will Ruin Your Retirement - July 08, 2020

From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.

ABBV : 99.52 (+0.17%)
BMY : 59.56 (-1.21%)
AMGN : 251.59 (-0.62%)
The Zacks Analyst Blog Highlights: Alibaba, NVIDIA, Bristol Myers Squibb, PetroChina and S&P Global

The Zacks Analyst Blog Highlights: Alibaba, NVIDIA, Bristol Myers Squibb, PetroChina and S&P Global

NVDA : 408.64 (+3.49%)
PTR : 37.35 (+3.26%)
BMY : 59.56 (-1.21%)
BABA : 257.68 (+8.95%)
SPGI : 354.32 (+3.85%)
Why Developments for Targeted Therapies Are Expected to Drive Sales for Brain Tumor Drug Market

, /PRNewswire/ -- The global brain tumor drugs market was valued at about in 2018 and is expected to grow to at a CAGR of 9.2% through 2022. The brain tumor drugs market consist of sales of drugs which...

CNSP : 2.06 (+5.64%)
VBIV : 3.95 (+17.56%)
PDSB : 1.9000 (-7.32%)
CRDF : 4.78 (-1.65%)
CLVS : 6.75 (+2.58%)
BMY : 59.56 (-1.21%)
Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know

Bristol Myers Squibb (BMY) closed at $60.29 in the latest trading session, marking a +0.17% move from the prior day.

BMY : 59.56 (-1.21%)
Top Stock Reports for Alibaba, NVIDIA & Bristol Myers Squibb

Top Stock Reports for Alibaba, NVIDIA & Bristol Myers Squibb

SPGI : 354.32 (+3.85%)
PTR : 37.35 (+3.26%)
NVDA : 408.64 (+3.49%)
JNJ : 143.27 (+0.29%)
BMY : 59.56 (-1.21%)
BABA : 257.68 (+8.95%)
Zacks.com featured highlights include: Bristol-Myers Squibb, Vale, Gilead Sciences, Kroger and Delek Logistics Partners

Zacks.com featured highlights include: Bristol-Myers Squibb, Vale, Gilead Sciences, Kroger and Delek Logistics Partners

GILD : 75.61 (-1.06%)
BMY : 59.56 (-1.21%)
VALE : 10.76 (+2.77%)
KR : 32.42 (-3.74%)
DKL : 24.06 (+0.71%)
Watch for Bristol-Myer Sqb to Potentially Pullback After Gaining 2.01% Yesterday

Bristol-Myer Sqb (NYSE:BMY) traded in a range yesterday that spanned from a low of $58.87 to a high of $60.45. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of...

BMY : 59.56 (-1.21%)
Seattle Genetics' Adcetris Progresses Well Amid Competition

Seattle Genetics (SEGN) focuses on improving sales of its flagship product, Adcetris. Further, label expansions of the drug should continue to boost the top line.

RHHBY : 44.1200 (+1.17%)
MRK : 77.92 (-1.02%)
BMY : 59.56 (-1.21%)
SGEN : 174.89 (-0.71%)
5 High Earnings Yield Stocks for a Winning Portfolio

Earnings yield is very important in comparing a stock with other stocks and with fixed income securities. A stock with higher earnings yield fetches better returns.

GILD : 75.61 (-1.06%)
BMY : 59.56 (-1.21%)
VALE : 10.76 (+2.77%)
KR : 32.42 (-3.74%)
DKL : 24.06 (+0.71%)
Pharma Stock Roundup: PFE's Coronavirus Vaccine Study, Approvals in Focus

Pfizer (PFE) releases promising early results from its COVID-19 vaccine study. Several new drug/line extensions get approval in the United States, EU and Japan.

JNJ : 143.27 (+0.29%)
SNY : 51.52 (+0.17%)
RHHBY : 44.1200 (+1.17%)
PFE : 33.80 (-0.68%)
MRK : 77.92 (-1.02%)
GSK : 40.73 (+0.87%)
BMY : 59.56 (-1.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade BMY with:

Business Summary

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in...

See More

Key Turning Points

2nd Resistance Point 61.24
1st Resistance Point 60.40
Last Price 59.56
1st Support Level 59.00
2nd Support Level 58.44

See More

52-Week High 68.34
Last Price 59.56
Fibonacci 61.8% 58.46
Fibonacci 50% 55.41
Fibonacci 38.2% 52.36
52-Week Low 42.48

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar